Table 1.
Phase A | Phase B | |||
---|---|---|---|---|
Study | Patient | Clonotype | Clonotype with | Clonotype with |
(only diagnosis samples) | identified | frequency >100 | VDJ homology >80% | |
Pilot 1 | A | 1616 | 12 | 7 |
B | 1703 | 59 | 33 | |
C | 2149 | 72 | 44 | |
D | 870 | 10 | 5 | |
E | 1398 | 35 | 21 | |
Average value | 1547 | 38 | 22 | |
Pilot 2 | A | 96 | 18 | 6 |
B | 278 | 72 | 11 | |
E | 77 | 5 | 0 | |
Average value | 150 | 32 | 6 |
For each patient of both Pilot studies the total number of identified clonotypes (third column) is reported. The number of clonotypes with a frequency greater than 100 were selected and passed the Phase A are reported in fourth column. Then from the Phase A, clonotypes with a VDJ homology greater than 80% were selected and passed the Phase B (fifth column). The average value are reported in bold